Kanokwaroon Watananirun

Kanokwaroon Watananirun

Auto-generated profile, based on publicly available information

Kanokwaroon Watananirun

My FetUZ Fetal Research Center, Department of Development and Regeneration Cluster Women and Child, Biomedical Sciences, KU Leuven Leuven Belgium

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 August 2022 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
BPBuraya Phattanachindakun
Buraya Phattanachindakun
KWKanokwaroon Watananirun
Kanokwaroon Watananirun
DBDittakarn Boriboonhirunsarn
Dittakarn Boriboonhirunsarn
A total of 1016 pregnant women attending antenatal clinic before 20 weeks of gestation during September 2018 to February 2019 were included in a cohort study with repeated cross-sectional assessments. The study was aimed to determine prevalence and characteristics of gestational diabetes mellitus (GDM) and pregnancy outcomes by early universal screening approach. GDM screening was performed during first visit and repeated during 24-28 weeks of gestation, as necessary, using a 50-g glucose challenge test followed by a 100-g oral glucose tolerance test for GDM diagnosis. Overall prevalence of GDM was 18.6%. A significantly higher prevalence of GDM was observed among high-risk than low-risk women (21.3% vs. 13.1%, p = 0.002). GDM among low-risk women contributed to 23.3% of all GDM cases. The majority of GDM (76.2%) were diagnosed before 20 weeks of gestation, with 74.5% occurring in high-risk women and 81.8% occurring in low-risk women. When initial screening tests were normal, risk of GDM diagnosed during 24-28 weeks was 6.0% (7.5% among high-risk women and 3.1% among low-risk women). Compared to those without GDM, women with GDM significantly had lower gestational weight gain (p < 0.001), higher prevalence of preeclampsia (p = 0.001), large for gestational age (LGA) (p = 0.034) and macrosomia (p = 0.004). These outcomes were more pronounced among high-risk women with GDM. Impact Statement What is already known on this subject? Universal GDM screening is recommended during 24-28 weeks of gestation, either by 1- or 2-step approach. Some also recommend early GDM screening among high-risk women. Prevalence of early-onset GDM varies between studies and benefits of early diagnosis and treatment are still controversial. What do the results of this study add? Early universal GDM screening identified more women with GDM and majority could be diagnosed before 20 weeks of gestation. GDM among low-risk women contributed to 23.3% of all cases. Adverse pregnancy outcomes were more common among high-risk women with GDM. This approach could be useful and can be implemented in other settings, especially those that serve high-risk population or with high GDM prevalence. What are the implications of these findings for clinical practice and/or further research? Early universal GDM screening should be considered in settings with high prevalence of GDM and high-risk women. However, benefits of early detection and treatment of GDM should be determined in more details in the future, especially in terms of cost-effectiveness and improvement in pregnancy outcomes.

19 March 2024 in Prenatal Diagnosis
Verified
Journal Article
Closed access
KWKanokwaroon Watananirun
Kanokwaroon Watananirun
AVAnna M. L. F. Vargas
Anna M. L. F. Vargas
SVSimen Vergote
Simen Vergote
Liesbeth LewiLiesbeth Lewi
Liesbeth Lewi
MFMarcelo O. L. Filippo
Marcelo O. L. Filippo
JDJan Deprest
Jan Deprest

27 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TATomohiro Arai
Tomohiro Arai
MBMichael A Belfort
Michael A Belfort
DBDavid Basurto
David Basurto
MSMarianna Scuglia
Marianna Scuglia
KWKanokwaroon Watananirun
Kanokwaroon Watananirun
LJLuc Joyeux
Luc Joyeux
Objectives: To determine whether a fetal lamb model reproducibly induces complex gastroschisis at term with its associated structural and functional bowel changes, and to compare its occurrence and associated bowel findings at different post-induction intervals. Methods: Gastroschisis was surgically induced in fetal lambs at gestational day 75 by creating a standardized abdominal wall defect stabilized with a silicone ring. Fetuses were assessed at term or at mid-gestation (13–21 days after induction), using non-operated littermates as controls. The primary outcome was occurrence of complex gastroschisis (bowel stenosis, atresia, volvulus, perforation, or necrosis) in survivors. At mid-gestation, this was compared between early (13–16 days) and late (17–21 days) groups, using Fisher’s exact test. Sample size for the primary outcome at term was determined a priori (α=0.05, 80% power). Mid-gestation sample size was determined using the same statistical assumptions, informed by an initial exploratory cohort. Secondary outcomes included prenatal and in vivo imaging, ex vivo bowel contractility, amniotic fluid composition, and histology. Results: Gastroschisis was induced in 32 fetuses. In the term cohort (n=14), 50% survived (7/14); all survivors had complex gastroschisis, with impaired bowel motility, altered enteric neural contractile responses, and smooth muscle remodeling compared with controls. Among fetuses assessed at mid-gestation (n=18), two died in utero; complex gastroschisis occurred more frequently in the late (5/7, 71%) than in the early (1/9, 11%; p =.04) group. Mid-gestation fetuses with gastroschisis had greater intra-abdominal bowel dilation on ultrasound and higher amniotic fluid digestive enzyme levels than controls, with the greatest dilation in fetuses with complex gastroschisis. Conclusions: This fetal lamb model reproducibly induced complex gastroschisis with structural and functional bowel changes in surviving lambs at term. Complex gastroschisis occurred more frequently at 17–21 than at 13–16 days after induction. At mid-gestation, fetuses with gastroschisis showed greater bowel dilation and differences in amniotic fluid composition than controls, whereas structural and functional bowel changes were not detected.

26 September 2026 in Prenatal Diagnosis
Verified
Journal Article
Open access
PDF file
TATanchanok Auwattanamongkol
Tanchanok Auwattanamongkol
NPNisarat Phithakwatchara
Nisarat Phithakwatchara
KNKatika Nawapun
Katika Nawapun
SVSommai Viboonchart
Sommai Viboonchart
SJSuparat Jaingam
Suparat Jaingam
TWTuangsit Wataganara
Tuangsit Wataganara
Objective: In monochorionic diamniotic twins with selective fetal growth restriction (sFGR), the Gratacós type is defined by one vessel in one fetus. We asked how much cerebral, venous and myocardial divergence between co‐twins it captures. Method: Single‐center combined retrospective–prospective cohort; one diagnostic examination per pregnancy. Six larger‐minus‐smaller contrasts were estimated by mixed‐effects models on outcome‐specific complete pairs. Observed‐profile likelihood characterized type‐specific phenotypes; HC3 models, bootstrapping and Holm/Benjamini–Hochberg correction tested between‐type differences and determinants. Results: Eighty‐two pregnancies were included (type I, 27; II, 51; III, 4). The larger co‐twin had higher MCA‐PI and biventricular MPI and lower MCA‐PSV and DV‐PIV (all Holm p ≤ 0.006). A coordinated arterial–venous and biventricular profile characterized type II/III alone, yet between‐type separation was confined to MCA‐PI (1.19 z ; 95% CI 0.49–1.88; Holm p = 0.009); neither MPI contrast survived correction. Weight discordance tracked MCA‐PSV asymmetry (−0.14 MoM per 10%; Holm p = 0.018), and type modified DV‐PIV asymmetry across gestational age (−1.25 z per 2 weeks; Holm p = 0.017), retained excluding type III. Conclusion: Umbilical‐artery type is mirrored principally by cerebral redistribution. Myocardial alteration is present, including in the larger co‐twin, but did not separate types at this sample size, remaining a research phenotype.

11 May 2026 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
SVS. Vergote
S. Vergote
LVL. Van der Veeken
L. Van der Veeken
EEE. Van Den Eede
E. Van Den Eede
TAT. Arai
T. Arai
KWK. Watananirun
K. Watananirun
COCollaborators
Collaborators